MYTREX F Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mytrex F, and when can generic versions of Mytrex F launch?
Mytrex F is a drug marketed by Savage Labs and is included in two NDAs.
The generic ingredient in MYTREX F is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mytrex F
A generic version of MYTREX F was approved as nystatin; triamcinolone acetonide by FOUGERA PHARMS INC on October 8th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYTREX F?
- What are the global sales for MYTREX F?
- What is Average Wholesale Price for MYTREX F?
Summary for MYTREX F
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| DailyMed Link: | MYTREX F at DailyMed |
US Patents and Regulatory Information for MYTREX F
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | MYTREX F | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 062597-001 | Oct 8, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Savage Labs | MYTREX F | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 062601-001 | Oct 9, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
